These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6785657)

  • 21. Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness.
    Solberg LI; Maciosek MV; Edwards NM; Khanchandani HS; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):62-71. PubMed ID: 16777544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening: current possibilities, new controversies?].
    Mackenbach JP
    Ned Tijdschr Geneeskd; 1995 Apr; 139(14):734-9. PubMed ID: 7731471
    [No Abstract]   [Full Text] [Related]  

  • 23. Health economic concepts, issues & challenges.
    Mukhopadhyay SP
    Indian J Public Health; 1994; 38(4):124-32. PubMed ID: 7797311
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cost-effectiveness of prevention: opportunities for public health policy in the Netherlands].
    van den Berg M; de Wit GA; Vijgen SM; Busch MC; Schuit AJ
    Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1329-34. PubMed ID: 18661860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer screening: problems and benefits.
    Smeltzer C; Vrba PD
    Nurs Manage; 1982 Apr; 13(4):52-5. PubMed ID: 6811980
    [No Abstract]   [Full Text] [Related]  

  • 26. [Guidelines and costs].
    Casparie AF; van Hout BA; Simoons ML
    Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2075-7. PubMed ID: 9856218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN
    Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
    [No Abstract]   [Full Text] [Related]  

  • 28. Financing preventive care in HMOs: a theoretical analysis.
    Dowd BE
    Inquiry; 1982; 19(1):68-78. PubMed ID: 6461602
    [No Abstract]   [Full Text] [Related]  

  • 29. [The need for preventive measures. Need for preventive measures at any price? Attempt at an argument in favor of the need for prevention not only for economic reasons].
    Nadolski H; Stegemann K; Preissig AB
    Gesundheitswesen; 1996; 58(8-9):432-41. PubMed ID: 9011258
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventive health care for older people. What's realistic?
    Kane RL
    Minn Med; 2002 Sep; 85(9):12-3. PubMed ID: 12387115
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention and rehabilitation as a means of cost containment: the example of myocardial infarction.
    Luginbuhl WH; Forsyth BR; Hirsch GB; Goodman MR
    J Public Health Policy; 1981 Jun; 2(2):103-15. PubMed ID: 6788801
    [No Abstract]   [Full Text] [Related]  

  • 32. Researchers explore cost-effective HIV preventions.
    AIDS Policy Law; 2005 Jul; 20(14):5. PubMed ID: 16108123
    [No Abstract]   [Full Text] [Related]  

  • 33. AIDS prevention more cost-effective than HAART treatment.
    AIDS Policy Law; 2002 Jun; 17(11):2. PubMed ID: 12083037
    [No Abstract]   [Full Text] [Related]  

  • 34. [Health policy--prevention rarely pays. Interview by Mette Fjordbo].
    Alban A
    Sygeplejersken; 1993 Mar; 93(13):22-3. PubMed ID: 8211725
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV prevention programs proven cost-effective.
    AIDS Alert; 1998 Sep; 13(9):107-8. PubMed ID: 11365792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of resource allocation models in selecting clinical preventive services.
    Wang LY; Haddix AC; Teutsch SM; Caldwell B
    Am J Manag Care; 1999 Apr; 5(4):445-54. PubMed ID: 10387384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is screening for scoliosis useful?].
    Baecke JA; Pessers FG; Verbeek AL
    Ned Tijdschr Geneeskd; 1984 Oct; 128(43):2028-32. PubMed ID: 6438536
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 39. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
    Reintjes R; Bosman A; de Zwart O
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1777-80. PubMed ID: 10494329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Most valuable preventive services don't reach targeted populations.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Jul; 12(15):1-2, 5. PubMed ID: 12222563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.